Navigation Links
New Studies Reporting a Higher Incidence of Child Abuse in ADHD and Dyslexia Suggest a Need for Early Medical Treatment, Notes Dr. Harold Levinson
Date:7/22/2014

Great Neck, N.Y. (PRWEB) July 22, 2014

Two recent studies indicate that previously untreated adults with dyslexia and ADHD were significantly more abused as children than those without these disorders. And a prior Harvard study noted that stimulant treatment for ADHD children reduces their otherwise higher risk of later addiction and alcohol dependence. However, the data did not reveal causation.

Since over 25% of the population suffer from dyslexia and ADHD, it is imperative to clarify the origins and best treatment for these disorders so as to prevent child abuse and addiction as well as a wide-range of other severe impairments from secondarily arising.

Because Dr. Levinson has examined and successfully treated over 35,000 children and adults with dyslexia and/or ADHD, his clinical insights are considered especially helpful.

Levinson’s four decades of "challenging" research has demonstrated that both ADHD and dyslexia are caused by a primary fine-tuning impairment within the cerebellar-vestibular or “inner-ear” systems— triggering both sensory and motor signal- scrambling.

Accordingly, ADHD occurs when initially normal frontal lobe and related brain mechanisms fail to descramble the distorted concentration and activity signals received and modulated. Similarly, a diverse range of dyslexia symptoms occur when normal parietal and other vital brain structures fail to descramble the “dizzy” reading, writing, spelling and other signals received and transmitted.

Fortunately, there are very favorable therapeutic modalities available for ADHD and/or dyslexia. Were children with the above frequently overlapping disorders properly diagnosed and treated early, both their childhoods and adult lives would be substantially normalized.

"Rapid emotional, behavioral and academic successes often occur when selective combinations of stimulants and related inner-ear-enhancing medications are properly used for ADHD and dyslexia," notes Levinson. "When other slowly helpful modalities are added, they're much more effective and the improvement rate approaches 100%."

By contrast, without vital "normalizing" medical help many dyslexic and ADHD children continue to inwardly feel flawed, dumb, “brainless,” irregardless of IQ. Indeed, the smarter they are the dumber they feel. Prone to increased stress, frustration and repeated failures as well as diminished self-esteem, many feel guilty. As a result, some invite or tolerate punishment and abuse or bullying while others act-out their frustration and anger by abusing others.

Too many of these failing children drift into drugs, attempting to escape their handicap and numb debilitating emotional pain. Their inability to normally function intensifies all other predisposing factors, thereby significantly explaining their higher risks or comorbidity for physical abuse, addiction, depression, anxiety, etc.

Without an in-depth and balanced understanding of the pros and cons of properly prescribed and monitored helpful medications, many caring parents and dedicated individuals may not fully appreciate the remarkable short and long-term benefits possible. And others may naturally fear side-effects and so avoid medication use. However, Levinson’s clinical experience as well as corroborating scientific evidence such as that presented suggest that the risks (e.g., child and drug abuse, etc.) of non-pharmacological treatment for ADHD and dyslexia are greater.

“By analogy, consider medications equivalent to cars, trains and planes,” states Levinson. “When properly maintained and ‘driven,’ benefits are maximized and risks are minimized. If meds are improperly administered and monitored—poorly ‘driven,’ then the fault lies with the prescriber or unsupervised abuser, not the meds.”

“I always start medications, irregardless of their nature, in very low doses, titrate up slowly, and tolerate absolutely no side-effects. A patient's need for steadily increasing doses or non-compliant acting-out is considered a major side-effect. When any negative drug effect initially occurs, they’re often minimal and rapidly disappear as soon as doses or meds are immediately reduced, changed or stopped. As a result, I seldom see significant side-effects--mainly significant benefits."

About Harold Levinson, M.D.:
Formerly Clinical Associate Professor of Psychiatry at New York University Medical Center, Dr. Harold Levinson is currently Director of the Levinson Medical Center for Learning Disabilities in Long Island, New York. He is a well-known neuropsychiatrist, clinical researcher and author. For more information, call 1(800)334-7323 or
visit: http://dyslexiaonline.com.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12029599.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Team studies immune response of Asian elephants infected with a human disease
2. Alzheimers Rate Falling in the United States, Studies Show
3. Eye Tests Might Help ID Alzheimers, Studies Suggest
4. EurekaMag.com Publishes 64,900 New Studies on Hepatitis C
5. University of Nevada, Reno continues $10 million biomedical studies for COBRE grant
6. Studies: Addiction starts with an overcorrection in the brain
7. Fifty percent of quality improvement studies fail to change medical practices
8. Taking the random out: New approach to medical studies could boost participation
9. Researchers publish one of the longest longitudinal studies of cognition in MS
10. Crescendo Bioscience to present multiple studies at 2014 EULAR Meeting
11. Mount Sinai researchers to present studies at American Society of Clinical Oncology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... ... Dr. David Mahon leads Siena Dental, a comprehensive dental practice located at ... Top Patient Rated Henderson Dentist by Find Local Doctors earlier this year. ... dentists who have earned high ratings and superior patient reviews from multiple credible sources. ...
(Date:2/23/2017)... ... , ... ERT, a global data and technology company that ... leading clinical development service provider, has selected ERT’s Trial Oversight suite as its ... to an array of circumstances including the use of multiple data capture modalities ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... publication and community for those in the fight against cancer, has produced a ... their success. HRA will release top-line findings in a webinar, Defining Compassionate ...
(Date:2/23/2017)... ... (PRWEB) February ... for the nation to come together to combine its favorite ... with its favorite fruit – apples! To celebrate National Nutrition ... join the “Apple Madness” bracket tournament – a five-week, five-round ...
(Date:2/23/2017)... ... February 23, 2017 , ... Top cosmetic and periodontal dentist Dr. Mahnaz ... a new Indiegogo campaign . Individuals are now able to contribute to the ... area, either as a participating patient or through an Indiegogo donation. The entirety of ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Feb. 23, 2017 AcelRx Pharmaceuticals, Inc. ... the development and commercialization of innovative therapies for ... it will release fourth quarter and yearly financial ... 2017. AcelRx management will host an investment-community conference ... Pacific Time) on March 2 nd 2017 ...
(Date:2/23/2017)... ... has announced the addition of the "Global Antifungal Drugs Market Analysis ... The Global Antifungal Drugs Market is poised to grow ... approximately $12.8 billion by 2025. This industry report ... global as well as regional levels presented in the research scope. The ...
(Date:2/23/2017)... 2017 The top three players ... Healthcare, Koninklijke Philips N.V., and Schiller. Collectively, these companies ... market in 2015. Strong product portfolio and a monumental ... be aiding these players remain leaders in the fragmented ... in the global market are likely to focus on ...
Breaking Medicine Technology: